Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops - Investor's Business Daily

The company said it plans to investigate a positive signal from female patients.

By: Investor's Business Daily

Jan 03 2025
0
0 Views

Neumora Therapeutics (NMRA) stock collapsed Thursday after its experimental depression treatment failed in the first of three studies planned by the biotech company. XNOW PLAYINGHow To Sell Stocks: … [+2449 chars]

I've taken my family to 5 major steakhouse chains in the US. We enjoyed most, but one is the best by a landslide. - Business Insider

This factor makes 11 stocks look like better bargains even after they soared in 2024 - MarketWatch

Nintendo Download: 2nd January (North America) - Nintendo Life

Carvana: A Father-Son Accounting Grift For The Ages - Hindenburg Research

Wall St rises in first trading session of 2025; Tesla slides - Reuters

Tesla’s Annual EV Sales Drop for First Time in Over a Decade - Yahoo Finance

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network